Skip to main content

Lavaca Capital LLC

Position in MRK — Merck & Co., Inc.

CIK 1641447 HOUSTON, TX

Position in MRK

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$8,451,830
+$6,766,086 QoQ
Shares Held
65,773
+369.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.90%
of 13F equity value
Holder Rank
#804
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in MRK Over Time

Shares Held

Position Value (USD)

Derivatives in MRK

reported options exposure · as of Mar 31, 2023
CallValue
$0
CallShares
0
PutValue
$2,563,999
PutShares
24,100

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Lavaca Capital LLC holds $11,294,866 across 14 Drug Manufacturers - General names. MRK ranks #1 (74.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MRK
Merck & Co., Inc.
This page
65,773 $8,451,830

All Filings in MRK

Export CSV
30 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $8,451,830 65,773
2026-03-31 $1,685,744 14,014
2025-12-31 $1,140,386 10,834
2025-09-30 $909,297 10,834
2025-06-30 $857,619 10,834
2025-03-31 $972,459 10,834
2024-12-31 $1,116,663 11,225
2024-09-30 $1,230,309 10,834
2024-06-30 $1,328,869 10,734
2024-03-31 $1,416,351 10,734
2023-12-31 $970,278 8,900
2023-09-30 $1,165,599 11,322
2023-06-30 $2,528,656 21,914
2023-03-31 $2,563,999 24,100
2023-03-31 $6,888,326 64,746
2022-12-31 $2,673,895 24,100
2022-12-31 $7,102,908 64,019
2022-09-30 $5,344,865 62,063
2022-09-30 $2,075,492 24,100
2022-06-30 $2,197,197 24,100
2022-06-30 $5,752,097 63,092
2022-03-31 $4,626,471 56,386
2021-12-31 $8,053,484 105,082
2021-09-30 $7,892,258 105,076
2021-06-30 $8,038,773 103,366
2021-03-31 $9,237,930 119,833
2020-12-31 $9,125,931 111,564
2020-09-30 $7,420,046 89,452
2020-06-30 $7,102,144 91,842
2020-03-31 $7,127,641 92,639